Zoetis Inc Net Income per Employee (ZTS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zoetis Inc   (NYSE: ZTS)
 

Zoetis Inc Net Income per Employee

ZTS's Quarterly Results, Trends, Rankings, Statistics
Zoetis Inc 's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 180,414, but the productivity of Zoetis Inc 's 14,500 employees remained above the company average.
The Healthcare sector has seen employees of 42 other companies achieving higher income per employee. While Zoetis Inc 's total ranking has deteriorated compared to the previous quarter from 410 to 623.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZTS Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change -3.76 % -4.75 % 3.79 % 4.19 % 15.06 %
Net Income per Employee (TTM) $ 180,414 182,276 184,345 182,828 180,828
ZTS's Total Ranking # 623 # 410 # 148 # 231 # 502
Seq. Net Income Change 14.98 % -0.33 % -16.37 % 0.42 % 13.79 %

ZTS Company Profile >> Back to ZTS Efficiency Comparisons >> Compare ZTS Net Income per Employee to its Competitors

ZTS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 43
Healthcare Sector # 73
Overall Market # 623

Net Income per Employee Statistics
High Average Low
$ 184,345 $ 109,823 $ 23,379
(Dec 31 2025)   (Dec 31 2015)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Spero Therapeutics Inc   295,320.00 $ 7.383  Million 25 
Eton Pharmaceuticals Inc   288,363.64 $ 12.688  Million 44 
Adma Biologics Inc   261,139.10 $ 168.957  Million 647 
Siga Technologies Inc  247,213.16 $ 12.113  Million 49 
Interpace Biosciences Inc   239,676.47 $ 24.447  Million 102 
Lantheus Holdings Inc   230,766.97 $ 275.305  Million 1,193 
Entrada Therapeutics Inc   222,888.16 $ 33.879  Million 152 
Lensar Inc   219,520.00 $ 32.928  Million 150 
Standard Biotools Inc   218,267.35 $ 84.906  Million 389 
Meiragtx Holdings Plc  195,858.56 $ 78.931  Million 403 
Intuitive Surgical Inc   185,529.64 $ 3,157.900  Million 17,021 
Zoetis Inc   180,413.79 $ 2,616.000  Million 14,500 
Arcutis Biotherapeutics Inc   176,146.89 $ 62.356  Million 354 
Transmedics Group Inc   170,973.27 $ 153.534  Million 898 
Veracyte Inc   151,633.11 $ 114.483  Million 755 
Johnson and Johnson  149,410.51 $ 21,037.000  Million 140,800 
Puma Biotechnology Inc   149,262.57 $ 26.718  Million 179 
Iradimed Corporation  138,883.19 $ 23.055  Million 166 
Resmed Inc   133,974.76 $ 1,523.293  Million 11,370 
Community Health Systems Inc   132,258.06 $ 410.000  Million 3,100 
Collegium Pharmaceutical Inc   113,274.23 $ 47.915  Million 423 
Ani Pharmaceuticals Inc  109,895.88 $ 106.599  Million 970 
Entera Bio Ltd   109,500.00 $ 2.409  Million 22 
Idexx Laboratories Inc  103,605.09 $ 1,139.656  Million 11,000 
Lemaitre Vascular Inc   103,320.61 $ 67.675  Million 655 
Progyny Inc   91,860.98 $ 78.633  Million 856 


Date modified: 2026-09-08T22:05:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.